Figure 11.
Schematic representation of the three small molecule marketed drugs: (a) eptifibatide, (b) tirofiban, (c) lifitegrast, and (d) zalunfiban (RUC-4), compound in the Phase 3 clinical trial.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.